
Oncology NEWS International
- Oncology NEWS International Vol 4 No 5
- Volume 4
- Issue 5
Blue-Light Endoscope Trial Closed
RICHMOND, BC, Canada--Xillix Technologies Corp. has closed the North American multicenter clinical trial of its LIFE (lung imaging fluorescence endoscope)-Lung Imaging System that began in April, 1993.
RICHMOND, BC, Canada--Xillix Technologies Corp. has closed theNorth American multicenter clinical trial of its LIFE (lung imagingfluorescence endoscope)-Lung Imaging System that began in April,1993.
The system uses tissue autofluo-rescence to enhance the physician'sability to locate suspicious lung tissue for biopsy. By usingblue rather than conventional white light, the system can pickup subtle differences between precancerous or cancerous tissueand normal tissue, the company said.
Preliminary data showed a relative improvement of 161% in theability to identify suspicious tissue for moderate to severe dysplasiaor worse when the LIFE System was used as an adjunct to whitelight bronchoscopy versus white light bronchoscopy alone.
Articles in this issue
about 31 years ago
Genetic Therapy Gets NIH Patentabout 31 years ago
Fusion Product Delivers Potent Toxin to Malignant Cellsabout 31 years ago
Retinoic Acid May Enhance Chemo In Ovarian Ca Cellsabout 31 years ago
Compounds Block ras Gene Function Compounds Block ras Gene Functionabout 31 years ago
Companies Merge to Form NeXstarabout 31 years ago
Antiangiogenesis Tested in Pediatric Tumorsabout 31 years ago
Delivery of Effective Cyclophosphamide Metabolite Could Reduce Toxicityabout 31 years ago
New Director Attends Office of Alternative Medicine Advisory MeetingRelated Content


TIP113 HERTHENA-PanTumor01 (NCT06172478): Expansion of a Global Phase 2 Trial of HER3-DXd in Patients With Advanced/Metastatic HR+/HER2− Breast Cancer




















































